Format

Send to:

Choose Destination
See comment in PubMed Commons below
Cancer Epidemiol. 2012 Apr;36(2):161-8. doi: 10.1016/j.canep.2012.01.001. Epub 2012 Feb 6.

Postmenopausal hormone therapy and ductal carcinoma in situ: a population-based case-control study.

Author information

  • 1Center for Cancer Epidemiology and Prevention, Yale School of Public Health, Yale School of Medicine, New Haven, CT 06510, USA. lisa.calvocoressi@yale.edu

Abstract

BACKGROUND AND AIM:

The relationship between hormone therapy (HT) and invasive breast cancer has been extensively investigated, but the relationship between HT and in situ breast cancer has received relatively little attention. We examined the relationship between HT and ductal carcinoma in situ (DCIS) among postmenopausal women who participated in a population-based case-control study in Connecticut, USA.

METHODS:

This analysis included 1179 post-menopausal women (603 controls and 576 cases), who comprised a subset of a population-based case-control study that included all incident cases of breast carcinoma in situ (BCIS) in Connecticut and frequency-matched controls by 5-year age intervals.

RESULTS:

We found no association between DCIS and ever use of any HT (adjusted odds ratio (OR)=0.85, 95% confidence interval (CI): 0.65-1.11); of estrogen alone (adjusted OR=0.93; 95% CI: 0.68-1.29) or of estrogen and progesterone (adjusted OR=0.75; 95% CI: 0.52-1.08). There was also no association between DCIS and current use of these hormones. In addition, estimated risk of DCIS did not increase with duration of use of these preparations.

CONCLUSIONS:

These results add to a small literature that remains inconclusive. To determine whether HT poses risk of in situ breast cancer, larger studies with greater power and precise control of important covariates (e.g., mammography screening) are needed, as are meta-analyses of available data.

Copyright © 2012 Elsevier Ltd. All rights reserved.

PMID:
22317899
[PubMed - indexed for MEDLINE]
PMCID:
PMC3613248
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Write to the Help Desk